Catalent Receives Award For Its Innovative Combination Potent Product Launch Partnership With A Top 5 Multi-National Pharma Company




Catalent Receives Award for its Innovative Combination Potent Product Launch Partnership with a Top 5 Multi-National Pharma Company

Date: 10/26/2010

Somerset, NJ, October 26, 2010  — Catalent Pharma Solutions has won for the third year in a row “The Best Contract Manufacturing Project” award at the 2010 European Outsourcing Awards, again recognizing its industry leadership and excellence. In the award-winning project, Catalent brought extensive expertise in softgel technology, over-encapsulation, and packaging to partner with a leading pharmaceutical company to launch Duodart®, an innovative potent fixed dose combination therapy medicine.

Multiple Catalent experts from many disciplines and across several of its global sites worked with the partner to overcome developmental challenges for this highly innovative product. Going forward, commercial softgel manufacture of the product is in Catalent’s Beinheim, France facility and, after a joint investment into state-of-the-art sophisticated technology, the over-encapsulation, release testing and packaging of the product is provided by Catalent’s Schorndorf, Germany site. The process includes a complex over-encapsulation of a softgel and beads into a hard shell capsule to deliver a fixed dose combination in a convenient novel dose form.

“We were especially pleased with this award, as it recognizes Catalent’s strength in bringing together a wide range of deep expertise and delivery technologies to solve complex developmental challenges for our customers. We value our close collaboration with our partner to help them bring this important new product to market,” said John Chiminski, Catalent’s President and Chief Executive Officer. “We are also delighted to once again win this prestigious award.” 
This year Catalent was a finalist for the European Outsourcing Award in the Most Effective Scale-Up/Tech Transfer category for its involvement with the same product. Catalent was also a finalist in the Most Innovative Relationship category for its effective work on a new prenatal product formulation with a leading Japanese partner.

Launched in 2005, the European Outsourcing Awards recognize significant developments in contract services and rewards successful companies for their outstanding contributions and achievements throughout the year. The awards were created to celebrate and recognize excellence in R&D, marketing, business and technology across the pharmaceutical industry.

For further information, please contact Gwen Green at  gwen.green@catalent.com .

About Catalent

Headquartered in Somerset, New Jersey, Catalent is a leading provider of advanced dose form and packaging technologies, and development, manufacturing, packaging and printing services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,000 at 29 facilities worldwide and in fiscal 2010 generated more than $1.7 billion of annual revenue. For more information, visit www.catalent.com.

more products. better treatments. reliably supplied.™

DUODART is a registered trademark of Smithkline Beecham Ltd.